Project Grant K08DA065497
- Federal Project Grant Award Summary Baystate Medical Center, Inc. received a $187,023 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning September 1, 2025, with a completion date of August 31, 2030. This mentored research career development award funds a mixed-methods study evaluating Massachusetts's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program, a statewide Medicaid initiative...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Massachusetts Medical School a Project Grant totaling $1,171,950 under the Drug Use and Addiction Research Programs (CFDA 93.279) on July 15, 2025, with a completion date of March 31, 2030. This research grant funds the discovery and functional characterization of long non-coding RNAs (lncRNAs) in opioid use disorder (OUD) within the context of HIV at single-cell resolution. The project addresses...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Beth Israel Deaconess Medical Center a Project Grant totaling $1.21 million under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period of July 1, 2025 through March 31, 2030. This research initiative focuses on developing novel polyvalent HIV vaccines specifically designed to protect people who inject drugs (PWID) against intravenous HIV transmission. The research addresses a critical public...
- Federal Grant Award Summary The University of Massachusetts Medical School received a $1.5M Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through May 31, 2030. The award funds the COLAAB (Clinical Organization and Legal Agency Alliance Building) Study, an implementation science research initiative designed to improve access to Medications for Opioid Use Disorder (MOUD) within drug court...
- Federal Project Grant Award Summary Boston Medical Center Corporation received a $356,630 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2027. The grant supports research investigating how substance abuse impacts antibody responses in people living with HIV (PLWH), with particular focus on individuals with concurrent substance use histories (PWUSH). The...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston Children's Hospital a $489,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025 and concluding May 31, 2027. This research initiative develops and validates remote oral fluid testing procedures to assess cannabis non-use as a key outcome measure in clinical trials targeting younger adults aged 18-30 years with cannabis use disorder (CUD). The project...
- Federal Project Grant Award Summary Boston University received a $193,751 Career Development Award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning May 1, 2026 and concluding April 30, 2031. This grant supports the development of an independent researcher focused on improving substance use disorder (SUD) services through a rigorous training and research program. The primary deliverables include research examining variation in...
- Federal Project Grant Award Summary New York University School of Medicine received a $1.45 million Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective July 1, 2025, through March 31, 2030. This research project will characterize complex opioid use disorder (OUD) care trajectories and outcomes following acute service utilization through a population-based data linkage study. The primary deliverable is...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $472,370 Project Grant to Harvard T.H. Chan School of Public Health, with an award date of September 1, 2025, and completion date of August 31, 2027. Under the Drug Use and Addiction Research Programs (CFDA 93.279), this award funds implementation and evaluation of the Worker Input and Strategy Program (WISP), an evidence-based, participatory organizational intervention designed to address workforce...
- Federal Grant Award Summary MASS JCOIN II Clinical Research Hub The National Institute on Drug Abuse awarded the University of Massachusetts a $1,600,955 Project Grant, effective September 1, 2025 through May 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct implementation research on Massachusetts's Medicaid Inmate Exclusion Policy (MIEP) waiver. The award funds a clinical research study examining the impact of early Medicaid reinstatement—beginning 90 days...
The National Institute on Drug Abuse (NIDA) awarded Massachusetts General Hospital a $197,640 Project Grant on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a four-year clinical and economic research initiative through February 28, 2030. This award supports research designed to evaluate the clinical impact and cost-effectiveness of integrating infectious disease (ID) care into rapid-access substance use disorder (SUD) bridge clinics—transitional care models that provide timely initiation of medications for opioid use disorder and treatment for other substance use disorders. The research addresses the syndemic of SUD and infectious diseases among people who inject drugs (PWID), focusing on reducing drug overdose and injection-related infections through integrated care delivery. The project deliverables consist of two primary research components: (1) construction of a longitudinal database documenting clinical outcomes and healthcare utilization among PWID receiving care through bridge clinics versus standard outpatient care within Massachusetts General Hospital's health system, and (2) expansion and application of a novel simulation model to conduct cost-effectiveness analyses comparing bridge clinic models to traditional separate SUD and ID care delivery sites. These research products will generate evidence-based findings to inform healthcare policy and clinical practice regarding optimal service delivery models for individuals with concurrent substance use and infectious disease conditions.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $197.6k | 2/17/26 |